Doug Somers (Chair)
Doug Somers is a seasoned executive with global experience in both large multinational as well as small startup technology companies. As Co-President and CEO of the Cassidy Bay Group, he specializes in executive and team coaching, strategic planning, and overcoming business startup and growth challenges. Prior to his work with the Cassidy Bay Group, Doug co-founded and was CEO of Bridgewater Systems, a successful supplier of telecom software systems to the largest communications service providers.
Before Bridgewater Doug was Vice-president and General Manager of the global Network and Service Management business unit at Newbridge Networks Corporation. Doug has a BSc. in Electrical Engineering from Queen’s University, is a certified professional coach (CPCC), music composer, and is a member of Professional Engineers Ontario.
Dr. Ken E. Edgecombe
Dr. Edgecombe holds a Masters and a Ph.D. in Theoretical Chemistry from Dalhousie University. His research interests have ranged from drug design, protein structure, and solid state calculations to the application of topology to chemical systems (and other areas) and the understanding of basic atomic and molecular structure. He is an inventor with 2 patents and an author of 24 refereed publications, two of which are widely used in textbooks to illustrate concepts and another cited over 1600 times in refereed publications.
After holding teaching and research positions at Queen's University from 1988 to 1995, he joined IBM North America as the Program Manager of High Performance Computing (HPC) in the Scientific and Technical Systems and Solutions group. Since 1997 he has helped build the High Performance Computing Virtual Laboratory (HPCVL) into a $200M innovative research environment. HPCVL was selected by Backbone magazine in March 2013 as one of the “Best 10 Research Facilities” in Canada.
His current interests include extending what is called the computing “cloud” to research needing secure High Performance Research Computing, long-term and archival storage and access to digital research data. He has served on numerous committees including the National Initiatives Committee of Compute Canada and the Ontario HPC Council. In 2009 he served as Conference Chair for the High Performance Computing Symposium 2009 and in 2010 he was named the Carl C. Coffin Lecturer in the Department of Chemistry, Dalhousie University. In 2013 he also organized and chaired the symposium Complex Data and Analytics in Medical Research. He is currently a member of the Board of the Ontario Cancer Biomarker Network and a part of the InDOC management team who are responsible for developing Brain - CODE.
Dr. Gary Slater
In 1984, after receiving a Ph.D. from the Université de Sherbrooke (Sherbrooke, Québec, Canada), Gary Slater worked for six years at the Xerox Research Centre of Canada in Mississauga, Ontario. In 1990, he joined the Department of Physics at the University of Ottawa, where he was named Professor in 1996. From July 1997 to December 2000, Gary was Vice-Dean (Research) for the Faculty of Science and was then appointed Vice-Dean of the Faculty of Graduate and Postdoctoral Studies (FGPS) from January 2002 through June 2004. He was the Dean of the FGPS from January 2005 to December 2011. After six month of administrative leave, he started a 5-year mandate as Associate Vice-President International on July 1, 2012.
Dr. Slater is a specialist in the physics of polymers and macromolecules, and is a world-known expert in electrophoresis, DNA separation methods, microfluidics and nanofluidics. Dr. Slater received the 2001 Researcher of the Year Award from the University of Ottawa. He has been awarded the University of Ottawa Research Chair in Biological Physics in 2004, and he was elected Fellow of the American Physical Society in 2010 and of the Royal Society of Canada in 2012.
Dr. Tofy Mussivand, FRSC
Dr. Tofy Mussivand has established a Patient Care Simulation Centre and the Medical Devices Innovation Institute. He received the NRC Lifetime Achievement award and is a Fellow of the Royal Society, New York Academy of Sciences, European Academy of Sciences, American Society of Medical Engineering and Biological Engineering.
Mussivand received his undergraduate education and training in engineering and management. Following many successful years in senior positions in government, crown corporations and the private sector, Dr Mussivand went on to receive his doctorate in Medical Engineering and Medical Sciences at the University of Akron and Northeastern Ohio Universities Colleges of Medicine. Thereafter, Dr Mussivand joined the internationally acclaimed Cleveland Clinic where he gained invaluable knowledge and experience in the development of medical devices, artificial hearts and cardiac care. In 1989, Dr Mussivand was invited to return to Canada to continue his pioneering work in various areas.
Dr. Mussivand has published over 500 books, papers, technical reports, editorials. In 2008, one of the articles was ranked among the top 25 most reviewed online. He has trained over 600 students and directed advanced training of 6,000 healthcare professionals, by establishing an advanced patient simulation center.
George Angus CPA, CA, BCom is a general management and financial consultant located in the Ottawa region. Over the past 30 years George has been active in the technology sector as a Global Finance Director for Northern Telecom (Data and Optical) and Bell Northern Research, President of Fisher Scientific’s Canadian and Latin American operations, COO of SDTC a federally funded CleanTech granting and advocacy agency and most recently as a consultant to several local technology firms.
George has also been a member of the Board of several organizations most notably DNA Genotek where he was a member of the audit committee and supported the Board in the successful sale of the company.
Mr. Freen joined Bell-Northern Research as part of the original R&D team developing the DMS central office telephony switch both as a designer and Manager. Following that, he spent six years at Mitel Corporation at a Director level in R&D. The roles held at Mitel ranged from system design and architecture, to the management of the core call processing development. In 1987, Mr. Freen joined Newbridge Networks and was the architect and development Director for the Network Management products within the corporation.
In 1990 Mr. Freen moved to the Motorola Corporation where he was responsible for the development and deployment of packet radio networks. Following that, he spend two years at Raynet Corporation in Menlo Park California developing Operations Support Systems for fiber to the curb and digital loop carrier systems. Returning to Newbridge, Mr. Freen held the position of AVP of Network Management Development where he was responsible for all aspect of product development for the network management products at Newbridge.
In 1997 Mr. Freen co-founded Bridgewater Systems. Bridgewater built a portfolio of products including subscriber data management, policy control and service control. Mr. Freen served as CTO and Board member until 2010 and helped the company grow revenues to over $90M per year and become a TSX listed public company. Mr. Freen remained on the board until Amdocs acquired the company for $211M in August 2011. Subsequently Mr. Freen has been engaged in providing strategic consulting to startup companies. Russ has a B.A. in Computer Science and Math from York University, and a M.Sc. Computer Science from the University of Toronto.
Dr. Steven Liss
Steven N. Liss is the Vice-Principal Research at Queen’s University and a full Professor of Environmental Studies and Chemical Engineering at Queen’s. He is a graduate of the Universities of Western Ontario, BSc Hons (1980) and Saskatchewan, MSc (1983), PhD (1987). He is an internationally recognized researcher and is well known for his work on microbial structures, including extracellular polymeric substances, and processes in environmental and engineered systems, and water engineering.
Professor Liss has held positions at Agriculture Canada, AFRC Cambridge, UK, Ryerson University, and the University of Guelph, prior to joining Queen’s. Professor Liss is a member and Chair of a number of Boards and management groups as part of his role in supporting research and innovation across Canada. For his contributions to research in Canada, Professor Liss was awarded the Queen Elizabeth II Diamond Jubilee Medal in 2012.
Dr. Florence Dzierszinski
Dr. Dzierszinski has been with the CURO since January 2012, where she has effectively led the implementation of the restructured office, and taken on a number of national leadership roles in research administration on behalf of Carleton. Prior to Carleton, she held a CIHR Canada Research Chair at McGill University in the Institute of Parasitology, with an expertise in immunology and genetics. She has published her work in journals such as Immunity.
Her research was funded by grants and awards from CIHR, NSERC, CFI, CRC, and the March of Dimes. She has served on a number of peer-review panels (FQRNT, FRSQ, NSERC, Wellcome Trust, NSF, etc), and has demonstrated accomplishments in building successful and productive partnerships and collaborations, both national and international (U.S., France). Dr. Dzierszinski received her PhD in Cell and Molecular Biology from the University of Lille I (France) and worked for 6 years as a post-doctoral fellow and Research Associate at the Genomics Institute / University of Pennsylvania, Philadelphia (UPenn) prior to coming to McGill and now Carleton.
Giulio Maffini has over 40 years of experience as an entrepreneur, technology leader and consultant. He is a passionate advocate of innovation in the design of products and services. Giulio has a track record of forming strong teams and alliances. He has built award winning start-ups and created profitable business units inside large companies. Through a+i2 he now advises companies and governments on innovation, partnering and enterprise projects.
Prior to a + i2 Inc., (1993- 1999) Giulio was Vice President and co-founder of the MCI Systemhouse, VISION* Solutions unit. The VISION* Solutions unit which was purchased by Autodesk in 1999 and Giulio worked within Autodesk for two years till 2001 to assist with the transition. Giulio was also Co-Founder of Tydac Technologies, a leading Canadian GIS company, which received the Canada Award for Excellence in Innovation. Prior to that, he was Co-Founder and Senior Vice President of the DPA Group Inc.; Vice President of M.E. Lloyd and Associates in Halifax, Nova Scotia; and Director of Physical Services Task Group, (MAPC) Metropolitan Area Planning Committee.
Giulio was a past member of the United States National Research Council, Mapping Sciences Committee during the development of the NSDI policy strategies, he is a former Board Member of the Geomatics Industry Association of Canada (GIAC) and currently serves on the Board of Trustees for the High Performance Computing Virtual Lab (HPCVL) an R&D consortium of Queens, Ottawa and Carleton Universities and the Royal Military College. Giulio holds a Bachelor of Architecture (Honors) and Bachelor of Science in Architecture, McGill University (1970). He was awarded the Québec Minister of Education Gold Medal for Distinction in Architecture & received the Hugh McLennan Memorial Scholarship.
Wendell Brown Chairs the HPCVL Audit committee and is the VP, Business Development at Bedarra Research Labs (BRL). He has more than 25 years senior operational and corporate director experience in IT, healthcare and biotechnology industries. Prior to BRL, Wendell was Senior Vice President of Business Development at Emageon, responsible for corporate strategy, channels programs and M&A functions for the corporation. He also served as President and Chief Operating Officer of Camtronics Medical Systems Inc., Canada before it was acquired by Emageon in November 2005.
Prior to joining Camtronics, Wendell was Executive Vice President and Chief Operating Officer of VMI Medical, Inc. He held various senior management positions with MCI/SHL Systemhouse Inc. between 1993 and 1999. From 2005 to 2010 Wendell was a Director of DNA Genotek Inc (www.dnagenotek.com) where he was the Chair of the Audit Committee and a member of the Governance Committee.
Dr. Philip Bates
Profile to come.